Vascular Biogenics Ltd (VBLT)

[davidal66]

GR, I get the 105 deaths, but what is the meaning of 50 % of the patients have more than 12 months potential follow up, whichever occurs later?

It means if they event 105 patient deaths... but 50 % of the patients do not have more than 12 months potential follow up... the interim would be delayed until the 12 months potential follow up is hit? Say, there is a huge difference between VB-111 and Avastin? This could theoretically come into play. Interesting.